DuPont

The Carlyle Group Completes Acquisition of DuPont Performance Coatings

Kemira Profits Hit by Weak Titanium Dioxide Market

Slumping Pigment Demand Eats Into DuPont's Profit

Novozymes Says Efficiency Boost to Keep Margins High

Coolant Safety Row Puts the Heat on Europe's Carmakers

Cheap Shale Gas Gives Impetus to Bioplastics Growth

Power of the Sun

Sustainability in Industrial Production

U.S. Chemical Giants Cutting Jobs After a Devastating Third Quarter

DuPont to Cut 1,500 Jobs as Economic Storm Worsens

Topics • Chemistry

M&A in the Chemicals & Materials Sector in the First Half of 2012

Topics • Chemistry

The Chemicals Economy at Halftime in 2012

DuPont Wins 20-Year Ban on Kolon's Kevlar Rival

DuPont to Sell Car Paint Unit to Carlyle for $4.9 Billion

Syngenta to Buy DuPont Pest Control Unit for $125 Million

Citing Global Anxiety, DuPont Gets Cautious on 2012

Invista NY Trial against Ex-Owner DuPont Opens

New Facilities Spotlight Next-generation Biofuels

US Agriculture Companies Set Millions for Africa

DuPont Shortlists Bidders for Car Paint Unit

Sustaining Innovation

Latin American Drought Crimps Syngenta Sale

Cheap Natgas to Help US Chemical Makers' Earnings

Key Maker of Auto Resin May Be Out until Winter

DuPont Seeks New Bids for Car Paint Unit

DuPont Sees Protein Demand Lifting Soy Sales

BASF Defies Doomsters with Forecast for Growth

AkzoNobel Says Passing On Cost Rises After Q4 Hit

Huntsman Posts Higher Q4 Profit

DuPont Starts Unit Auction, May Fetch $4 Billion

Chinese Espionage Cases Touch DuPont, Motorola

Dow Chemical Profit, Revenue Miss; Shares Slip

U.S. Accuses China of Instigating Plot against DuPont

Obama to Ask Chemical Companies, Other U.S. Firms to Keep Jobs At Home

Hong Kong Science Park Plans $643 Million Green Tech Hub

59 more articles

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Expert Insights

ADCs for Precision Cancer Therapy

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Univers. St. Gallen

EDB Singapore

International Flavors & Fragrances Inc. (IFF)

LANXESS Deutschland GmbH

Managm. Consult. Chemicals

Society of Chemical Manufacturers & Affiliates (SOCMA)

Camelot Management Consultants AG

Together for Sustanability (TFS)

Enigma Marketing Research

DuPont Intern. Operat. Sarl

American Oil Chemists' Society (AOCS)

Dupont International Operations S.àr.l.

Squire Patton Boggs

Dechema e.V.

DuPont Company